385 related articles for article (PubMed ID: 8764625)
1. Magnetic resonance imaging of multiple sclerosis lesions. Measuring outcome in treatment trials.
Simon JH
West J Med; 1996 Jun; 164(6):502-9. PubMed ID: 8764625
[TBL] [Abstract][Full Text] [Related]
2. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.
Miller DH; Albert PS; Barkhof F; Francis G; Frank JA; Hodgkinson S; Lublin FD; Paty DW; Reingold SC; Simon J
Ann Neurol; 1996 Jan; 39(1):6-16. PubMed ID: 8572668
[TBL] [Abstract][Full Text] [Related]
3. [Magnetic resonance in the diagnosis and treatment of multiple sclerosis].
Rovira Cañellas A
Neurologia; 2000; 15(7):288-302. PubMed ID: 11075577
[TBL] [Abstract][Full Text] [Related]
4. Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinical trials.
Zivadinov R
Methods Find Exp Clin Pharmacol; 2009; 31(1):29-40. PubMed ID: 19357796
[TBL] [Abstract][Full Text] [Related]
5. The use of MRI as an outcome measure in clinical trials.
Li DK; Li MJ; Traboulsee A; Zhao G; Riddehough A; Paty D
Adv Neurol; 2006; 98():203-26. PubMed ID: 16400836
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives.
Bar-Zohar D; Agosta F; Goldstaub D; Filippi M
Mult Scler; 2008 Jul; 14(6):719-27. PubMed ID: 18424478
[TBL] [Abstract][Full Text] [Related]
7. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
Zivadinov R; Sepcić J
Lijec Vjesn; 2006; 128(9-10):295-308. PubMed ID: 17128669
[TBL] [Abstract][Full Text] [Related]
8. Validity of brain MRI as the primary outcome criterion in multiple sclerosis phase II clinical trials.
Liedtke W; Limmroth V
Ann Neurol; 1996 Feb; 39(2):276-7. PubMed ID: 8967762
[No Abstract] [Full Text] [Related]
9. Outcome measures in multiple sclerosis clinical trials.
Andersson PB; Goodkin DE
Baillieres Clin Neurol; 1997 Oct; 6(3):409-28. PubMed ID: 10101581
[TBL] [Abstract][Full Text] [Related]
10. Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis.
Filippi M; Horsfield MA; Adèr HJ; Barkhof F; Bruzzi P; Evans A; Frank JA; Grossman RI; McFarland HF; Molyneux P; Paty DW; Simon J; Tofts PS; Wolinsky JS; Miller DH
Ann Neurol; 1998 Apr; 43(4):499-506. PubMed ID: 9546332
[TBL] [Abstract][Full Text] [Related]
11. [Magnetic resonance imaging in multiple sclerosis].
Tourbah A; Berry I
Pathol Biol (Paris); 2000 Mar; 48(2):151-61. PubMed ID: 10815291
[TBL] [Abstract][Full Text] [Related]
12. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.
Barkhof F; van Walderveen M
Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1675-86. PubMed ID: 10603619
[TBL] [Abstract][Full Text] [Related]
13. The use of MR imaging as an outcome measure in multiple sclerosis clinical trials.
Bermel RA; Fisher E; Cohen JA
Neuroimaging Clin N Am; 2008 Nov; 18(4):687-701, xi. PubMed ID: 19068409
[TBL] [Abstract][Full Text] [Related]
14. MRI in multiple sclerosis.
Simon JH
Phys Med Rehabil Clin N Am; 2005 May; 16(2):383-409, viii. PubMed ID: 15893678
[TBL] [Abstract][Full Text] [Related]
15. MR in the diagnosis and monitoring of multiple sclerosis: an overview.
Rovira A; León A
Eur J Radiol; 2008 Sep; 67(3):409-14. PubMed ID: 18434066
[TBL] [Abstract][Full Text] [Related]
16. [Magnetic resonance and multiple sclerosis II. New diagnostic techniques].
Mathiesen HK; Langkilde AR; Larsson HB
Ugeskr Laeger; 2002 Feb; 164(8):1031-6. PubMed ID: 11894703
[TBL] [Abstract][Full Text] [Related]
17. Measuring brain atrophy in multiple sclerosis.
De Stefano N; Battaglini M; Smith SM
J Neuroimaging; 2007 Apr; 17 Suppl 1():10S-15S. PubMed ID: 17425728
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance in multiple sclerosis.
Paty DW
Curr Opin Neurol Neurosurg; 1993 Apr; 6(2):202-8. PubMed ID: 8481564
[TBL] [Abstract][Full Text] [Related]
19. Trial measures in multiple sclerosis: the use of magnetic resonance imaging in the evaluation of clinical trials.
Paty DW
Neurology; 1988 Jul; 38(7 Suppl 2):82-3. PubMed ID: 3386847
[No Abstract] [Full Text] [Related]
20. Magnetic resonance imaging in clinical therapeutic trials of multiple sclerosis.
Jacobs L
West J Med; 1996 Jun; 164(6):531-2. PubMed ID: 8764636
[No Abstract] [Full Text] [Related]
[Next] [New Search]
